240 related articles for article (PubMed ID: 28034917)
1. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
2. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
[TBL] [Abstract][Full Text] [Related]
3. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
4. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
[TBL] [Abstract][Full Text] [Related]
5. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
6. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.
Le YL; McFall SL; Byrd TL; Volk RJ; Cantor SB; Kuban DA; Mullen PD
Narrat Inq Bioeth; 2016; 6(1):51-61. PubMed ID: 27346824
[TBL] [Abstract][Full Text] [Related]
7. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
[TBL] [Abstract][Full Text] [Related]
8. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
9. Decision-making processes among men with low-risk prostate cancer: A survey study.
Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
[TBL] [Abstract][Full Text] [Related]
10. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
[TBL] [Abstract][Full Text] [Related]
11. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
[TBL] [Abstract][Full Text] [Related]
12. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
Davison BJ; Goldenberg SL
BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
[TBL] [Abstract][Full Text] [Related]
13. Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.
Tomer A; Rizopoulos D; Nieboer D; Drost FJ; Roobol MJ; Steyerberg EW
Med Decis Making; 2019 Jul; 39(5):499-508. PubMed ID: 31319751
[No Abstract] [Full Text] [Related]
14. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
[TBL] [Abstract][Full Text] [Related]
15. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
16. Expert panel advocates surveillance for men with low-risk prostate cancer.
Slomski A
JAMA; 2012 Jan; 307(2):133. PubMed ID: 22235075
[No Abstract] [Full Text] [Related]
17. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
Orom H; Homish DL; Homish GG; Underwood W
Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
[TBL] [Abstract][Full Text] [Related]
18. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.
Welty CJ; Cowan JE; Nguyen H; Shinohara K; Perez N; Greene KL; Chan JM; Meng MV; Simko JP; Cooperberg MR; Carroll PR
J Urol; 2015 Mar; 193(3):807-11. PubMed ID: 25261803
[TBL] [Abstract][Full Text] [Related]
19. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
20. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]